Literature DB >> 14742571

Needle-free skin patch vaccination method for anthrax.

Gary R Matyas1, Arthur M Friedlander, Gregory M Glenn, Stephen Little, Jianmei Yu, Carl R Alving.   

Abstract

Three immunizations of mice with recombinant protective antigen (rPA) by transcutaneous immunization (TCI) induced long-term neutralizing antibody titers that were superior to those obtained with aluminum-adsorbed rPA. In addition, rPA alone exhibited adjuvant activity for TCI. Forty-six weeks after completion of TCI, 100% protection was observed against lethal anthrax challenge.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14742571      PMCID： PMC321625          DOI： 10.1128/IAI.72.2.1181-1183.2004

Source DB:  PubMed          Journal:  Infect Immun        ISSN： 0019-9567            Impact factor:   3.441


  11 in total

1.  Search for correlates of protective immunity conferred by anthrax vaccine.

Authors:  S Reuveny; M D White; Y Y Adar; Y Kafri; Z Altboum; Y Gozes; D Kobiler; A Shafferman; B Velan
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

2.  Aluminum compounds as vaccine adjuvants.

Authors: 
Journal:  Adv Drug Deliv Rev       Date:  1998-07-06       Impact factor: 15.470

3.  Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin.

Authors:  P F Fellows; M K Linscott; B E Ivins; M L Pitt; C A Rossi; P H Gibbs; A M Friedlander
Journal:  Vaccine       Date:  2001-04-30       Impact factor: 3.641

4.  In vitro correlate of immunity in a rabbit model of inhalational anthrax.

Authors:  M L Pitt; S F Little; B E Ivins; P Fellows; J Barth; J Hewetson; P Gibbs; M Dertzbaugh; A M Friedlander
Journal:  Vaccine       Date:  2001-09-14       Impact factor: 3.641

Review 5.  Anthrax vaccines.

Authors:  A M Friedlander; S L Welkos; B E Ivins
Journal:  Curr Top Microbiol Immunol       Date:  2002       Impact factor: 4.291

6.  Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.

Authors:  L C Iacono-Connors; S L Welkos; B E Ivins; J M Dalrymple
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

7.  Aluminum-containing vaccine associated adverse events: role of route of administration and gender.

Authors:  Phillip R Pittman
Journal:  Vaccine       Date:  2002-05-31       Impact factor: 3.641

8.  Transcutaneous immunization: a human vaccine delivery strategy using a patch.

Authors:  G M Glenn; D N Taylor; X Li; S Frankel; A Montemarano; C R Alving
Journal:  Nat Med       Date:  2000-12       Impact factor: 53.440

9.  Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants.

Authors:  T Scharton-Kersten; J m Yu; R Vassell; D O'Hagan; C R Alving; G M Glenn
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

10.  Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously.

Authors:  Fernando Güereña-Burgueño; Eric R Hall; David N Taylor; Frederick J Cassels; Daniel A Scott; Marcia K Wolf; Zachary J Roberts; Galina V Nesterova; Carl R Alving; Gregory M Glenn
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441
View more
  13 in total

1.  Taking the sting out of the anthrax vaccine.

Authors:  Laurie Goodman
Journal:  J Clin Invest       Date:  2004-10       Impact factor: 14.808

Review 2.  Topical vaccination: the skin as a unique portal to adaptive immune responses.

Authors:  Chun-Ming Huang
Journal:  Semin Immunopathol       Date:  2007-04       Impact factor: 9.623

3.  Correlation between lethal toxin-neutralizing antibody titers and protection from intranasal challenge with Bacillus anthracis Ames strain spores in mice after transcutaneous immunization with recombinant anthrax protective antigen.

Authors:  Kristina K Peachman; Mangala Rao; Carl R Alving; Robert Burge; Stephen H Leppla; Venigalla B Rao; Gary R Matyas
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

4.  Anthrax LFn-PA Hybrid Antigens: Biochemistry, Immunogenicity, and Protection Against Lethal Ames Spore Challenge in Rabbits.

Authors:  Qin Li; Kristina K Peachman; Laurie Sower; Stephen H Leppla; Sathish B Shivachandra; Gary R Matyas; Johnny W Peterson; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  Open Vaccine J       Date:  2009

5.  Preferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.

Authors:  Behazine Combadière; Annika Vogt; Brice Mahé; Dominique Costagliola; Sabrina Hadam; Olivia Bonduelle; Wolfram Sterry; Shlomo Staszewski; Hans Schaefer; Sylvie van der Werf; Christine Katlama; Brigitte Autran; Ulrike Blume-Peytavi
Journal:  PLoS One       Date:  2010-05-26       Impact factor: 3.240

Review 6.  Binary bacterial toxins: biochemistry, biology, and applications of common Clostridium and Bacillus proteins.

Authors:  Holger Barth; Klaus Aktories; Michel R Popoff; Bradley G Stiles
Journal:  Microbiol Mol Biol Rev       Date:  2004-09       Impact factor: 11.056

7.  The mast cell activator compound 48/80 is safe and effective when used as an adjuvant for intradermal immunization with Bacillus anthracis protective antigen.

Authors:  Afton L McGowen; Laura P Hale; Christopher P Shelburne; Soman N Abraham; Herman F Staats
Journal:  Vaccine       Date:  2009-04-14       Impact factor: 3.641

Review 8.  Anthrax vaccination strategies.

Authors:  Robert J Cybulski; Patrick Sanz; Alison D O'Brien
Journal:  Mol Aspects Med       Date:  2009-09-01

9.  Anthrax vaccine antigen-adjuvant formulations completely protect New Zealand white rabbits against challenge with Bacillus anthracis Ames strain spores.

Authors:  Kristina K Peachman; Qin Li; Gary R Matyas; Sathish B Shivachandra; Julie Lovchik; Rick C Lyons; Carl R Alving; Venigalla B Rao; Mangala Rao
Journal:  Clin Vaccine Immunol       Date:  2011-11-16

Review 10.  Delivery systems for intradermal vaccination.

Authors:  Y C Kim; C Jarrahian; D Zehrung; S Mitragotri; M R Prausnitz
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.